Last of all, we also performed the subcutaneous tumour model and found that targeting HMGB1 could suppress the in vivo growth of tumours derived from the PHF10‐deleted cells, as evidenced by the quantification of tumour growth curve and tumour weight (Figure 5G–I). This evidence concerns the gene HMGB1 and neoplasm.